Dan Gibson
#178,214
Most Influential Person Now
Researcher
Dan Gibson's AcademicInfluence.com Rankings
Dan Gibsoncomputer-science Degrees
Computer Science
#11141
World Rank
#11771
Historical Rank
Machine Learning
#5092
World Rank
#5155
Historical Rank
Artificial Intelligence
#5490
World Rank
#5566
Historical Rank
Database
#8172
World Rank
#8522
Historical Rank
Download Badge
Computer Science
Dan Gibson's Degrees
- PhD Computer Science Stanford University
- Masters Artificial Intelligence University of California, Berkeley
Similar Degrees You Can Earn
Why Is Dan Gibson Influential?
(Suggest an Edit or Addition)Dan Gibson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))]. (1985) (366)
- The disposition of voriconazole in mouse, rat, rabbit, guinea pig, dog, and human. (2003) (291)
- What do we know about the reduction of Pt(IV) pro-drugs? (2012) (257)
- Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies. (2003) (178)
- Crystal and molecular structure of cis-[Pt(NH3)2{d(pGpG)}], the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA (1988) (176)
- Platinum(iv) anticancer prodrugs - hypotheses and facts. (2016) (151)
- The mechanism of action of platinum anticancer agents--what do we really know about it? (2009) (149)
- Pt(IV) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate. (2012) (124)
- Is glutathione the major cellular target of cisplatin? A study of the interactions of cisplatin with cancer cell extracts. (2009) (117)
- Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles. (2002) (106)
- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc04205d (2016) (105)
- DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines. (2003) (88)
- Facile preparation of mono-, di- and mixed-carboxylato platinum(IV) complexes for versatile anticancer prodrug design. (2013) (87)
- Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell lines. (2002) (85)
- Multi-action Pt(IV) anticancer agents; do we understand how they work? (2019) (83)
- Reduction of cis,trans,cis-[PtCl2(OCOCH3)2(NH3)2] by aqueous extracts of cancer cells. (2007) (83)
- A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines. (2017) (82)
- A Multiaction and Multitarget Ru(II)-Pt(IV) Conjugate Combining Cancer Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers. (2020) (81)
- Synthesis and antitumor activity of quinonoid derivatives of cannabinoids. (2004) (79)
- Triple action Pt(iv) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc00428e (2018) (74)
- Platinum(IV) prodrugs with haloacetato ligands in the axial positions can undergo hydrolysis under biologically relevant conditions. (2013) (69)
- Carbon-bonded beta-diketone complexes (1969) (69)
- The cytosolic pathway of l-malic acid synthesis in Saccharomyces cerevisiae: the role of fumarase (1996) (68)
- A Mass Spectral Study of the Binding of the Anticancer Drug Cisplatin to Ubiquitin (1999) (68)
- New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells. (2015) (64)
- New reduction pathways for ctc-[PtCl2(CH3CO2)2(NH3)(Am)] anticancer prodrugs. (2010) (63)
- In vivo biodistribution of platinum-based drugs encapsulated into multi-walled carbon nanotubes. (2014) (57)
- Activation of Trans Geometry in Bifunctional Mononuclear Platinum Complexes by a Piperidine Ligand (2003) (57)
- Cellular interactions of platinum drugs (2012) (57)
- Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands. (2014) (55)
- Dual-Targeting Dual-Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity. (2019) (53)
- A Lipophilic Pt(IV) Oxaliplatin Derivative Enhances Antitumor Activity. (2016) (51)
- The role of the catecholic and the electrophilic moieties of caffeic acid in Nrf2/Keap1 pathway activation in ovarian carcinoma cell lines (2014) (49)
- A MOLECULE CONTAINING THE OWOWO UNIT. SYNTHESIS, STRUCTURE AND SPECTROSCOPY OF HEXANEOPENTYLDITUNGSTEN TRIOXIDE (1985) (49)
- Nuclear localization signal-targeted poly(ethylene glycol) conjugates as potential carriers and nuclear localizing agents for carboplatin analogues. (2004) (49)
- Novel apoptosis-inducing trans-platinum piperidine derivatives: synthesis and biological characterization. (2002) (48)
- Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin. (2016) (48)
- Drug–DNA interactions and novel drug design (2002) (46)
- Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine. (2008) (41)
- THE HYDROGEN OXIDE BRIDGING LIGAND (H3O2-). 1. DIMERIZATION AND POLYMERIZATION OF HYDROLYZED TRINUCLEAR METAL CLUSTER IONS (1982) (41)
- Metal β-diketone complexes. Part VI. Some β-diketone complexes of copper(I), silver(I), and gold(I) (1970) (40)
- Preparation, characterization, and anticancer activity of a series of cis-PtCl2 complexes linked to anthraquinone intercalators. (1991) (39)
- The timing of caffeic acid treatment with cisplatin determines sensitization or resistance of ovarian carcinoma cell lines (2016) (33)
- A new bridging ligand, the hydrogen oxide ion (H3O2-) (1981) (33)
- The gas-phase chemistry of C4H4+− (1981) (32)
- Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts (2009) (32)
- A Subset of New Platinum Antitumor Agents Kills Cells by a Multimodal Mechanism of Action Also Involving Changes in the Organization of the Microtubule Cytoskeleton. (2019) (32)
- Peculiar mechanistic and structural features of the carboplatin–cytochrome c system revealed by ESI-MS analysis (2008) (31)
- Water soluble cationic trans-platinum complexes which induce programmed cell death in the protozoan parasite Leishmania infantum. (2005) (31)
- Molecular structure of the complex formed between the anticancer drug cisplatin and d(pGpG): C222(1) crystal form. (1990) (31)
- On the stability of Pt(IV) pro-drugs with haloacetato ligands in the axial positions. (2015) (31)
- Structure and unique interactions with DNA of a cationic trans-platinum complex with the nonplanar bicyclic piperidinopiperidine ligand. (2005) (30)
- Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates (2017) (30)
- Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies. (2006) (29)
- Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end? (2021) (27)
- Oxalato complexes of the trinuclear aquo ion of molybdenum(IV), [Mo3O4]4+ (1985) (27)
- Synthesis, characterization and in vitro and in vivo anticancer activity of Pt(iv) derivatives of [Pt(1S,2S-DACH)(5,6-dimethyl-1,10-phenanthroline)]. (2017) (26)
- Studies on cellular accumulation of satraplatin and its major metabolite JM118 and their interactions with glutathione. (2010) (25)
- Multinuclear (platinum-195, nitrogen-15, carbon-13) NMR studies of the reactions between cis-diaminediaquaplatinum(II) complexes and aminomalonate (1990) (25)
- Ligand effects on the binding of cis- and trans-[PtCl2Am1Am2] to proteins (2002) (25)
- Soybean oil emulsion administration during parenteral nutrition in the preterm infant: effect on essential fatty acid, lipid, and glucose metabolism. (1987) (25)
- Anthraquinone intercalators as carrier molecules for second-generation platinum anticancer drugs (1997) (24)
- Novel carboplatin analogs containing flexible and potentially intercalating ligands: preparation and X-ray crystal structures of di-2-pyridyl ketone cyclobutanedicarboxylate platinum(II) and of 2,3-bis(2-pyridyl)pyrazine cyclobutane dicarboxylate platinum(II) (1997) (24)
- Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro. (2010) (23)
- α-Oxyiminophosphonates: chemical and physical properties. Reactions, theoretical calculations, and X-ray crystal structures of (E) and (Z)-dimethyl α-hydroxyiminobenzylphosphonates (1988) (23)
- Expanding the Arsenal of PtIV Anticancer Agents; Multi-action PtIV Anticancer Agents with Bioactive Ligands Possessing Hydroxyl Functional Group. (2019) (22)
- An Anticancer PtIV Prodrug That Acts by Mechanisms Involving DNA Damage and Different Epigenetic Effects. (2019) (22)
- Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand (2005) (22)
- Preparation and structural characterization of a novel hexanuclear complex of platinum(II) with 2-aminoethanethiolate (1986) (21)
- Preparation, characterization, and antitumor properties of cis-PtCl2 complexes linked to anthraquinones through position number 2. (1995) (20)
- Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer Cells. (2020) (20)
- Synthesis and NMR structural studies of the adduct of trans-diamminedichloroplatinum(II) with the DNA fragment d(GpCpG) (1987) (20)
- Dicopper(I) tropocoronands: synthesis, X-ray crystal structure, and spectral properties of neutral binuclear copper(I) complexes bridged by symmetrically substituted alkynes (1985) (19)
- The trans labilization of cis-[PtCl2(13CH3NH2)2] by glutathione can be monitored at physiological pH by [1H,13C] HSQC NMR (2006) (19)
- Structure of the gas-phase ion C6H5+ (1980) (18)
- The hydrogen oxide bridging ligand (H3O2−). II: Effect of the hydrogen ion concentration (1984) (18)
- Reactions of phosphorus pentachloride with tin tetrachloride. Tetrachlorophosphonium salts with hexachlorostannate(2-), decachlorodistannate(2-), and pentachlorostannate(1-) anions: preparation and structure by vibrational spectra and x-ray crystallography (1985) (18)
- Novel amino acid derivatives. Preparation and properties of aminoacylphosphonates and amino hydroxyimini phosphonates (1990) (17)
- A Multi‐action and Multi‐target Ru II –Pt IV Conjugate Combining Cancer‐Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers (2020) (16)
- Stereoselectivity in fragmentation and rearrangement of α-hydroxyimino-phosphinates and -phosphonates. A synthetic approach to acylphosphon- and phosphor-amidates. Crystal structures of methyl (E)-α-hydroxyimino-benzylphenylphosphinate and methyl benzoylphenylphosphonamidate (1990) (16)
- Structure of a Diolefine Complex of Platinum(II) C10H14O3PtCl2 (1965) (15)
- Preparation, characterization and antileukemic properties of diaminemalonatoplatinum(II) complexes tethered to ferrocene (1992) (15)
- Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules. (2020) (15)
- Donor atom preferences in substitution reactions of trans-platinum mononucleobase compounds : Implications for DNA-protein selectivity (2006) (14)
- Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues. (2003) (14)
- Interactions of platinum complexes containing cationic, bicyclic, nonplanar piperidinopiperidine ligands with biological nucleophiles. (2006) (14)
- Alkyne-bridged dicopper(I) complexes of the tropocoronand macrocycles (1987) (14)
- Acylphosphonamidates and α‐hydroxyiminophosphonamidates. Synthesis of N‐acylphosphordiamidates by Beckmann rearrangement. Crystal structure of (E)‐α‐hydroxyiminobenzyl‐1‐pyrrolidinylphosphinate (1996) (13)
- DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)]. (2007) (12)
- PHARMACOKINETICS AND METABOLISM OF A NEW POTENT ANTIEPILEPTIC DRUG, 2,2,3,3-TETRAMETHYCYCLOPROPANECARBONYLUREA, IN RATS (2005) (12)
- Fragmentation of methyl hydrogen α-hydroxyiminophosphonates to monomeric methyl metaphosphate: stereochemistry and mechanism (1989) (12)
- trans-Platinum(iv) pro-drugs that exhibit unusual resistance to reduction by endogenous reductants and blood serum but are rapidly activated inside cells: 1H NMR and XANES spectroscopy study. (2020) (12)
- Metal complexes of .alpha.-hydroxyimino phosphonic acid derivatives. Separation of E and Z isomers by metal chelation and the preparation and characterization of copper bis[(E)-(.alpha.-(hydroxyimino)benzyl)phosphonate]-water (1989) (12)
- Preparation, characterization and the anticancer activity of a novel series of triaminemonochloroplatinum(II) cations linked to anthraquinone intercalators (1991) (12)
- Ternary Pt(II)-amino acid-nucleotide complexes: kinetics of formation (1994) (11)
- Dual‐Targeting Dual‐Action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity (2019) (11)
- Synthesis and Cytotoxicity of Water-Soluble Dual- and Triple-Action Satraplatin Derivatives: Replacement of Equatorial Chlorides of Satraplatin by Acetates. (2019) (10)
- Trinuclear Mo(IV) cluster ion with a propylidyne cap (1982) (10)
- α-Hydroxyiminophosphonic acids. New types of phosphorylating agents through monomeric metaphosphate (1988) (10)
- Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs? (2021) (10)
- Expanding the Arsenal of Pt IV Anticancer Agents: Multi‐action Pt IV Anticancer Agents with Bioactive Ligands Possessing a Hydroxy Functional Group (2019) (9)
- Metal–β-diketone complexes. Part II. Carbon-bonded platinum(II) complexes of trifluoroacetylacetone and benzoylacetone (1966) (9)
- Metal complexes of α-hydroxyiminophosphonic acid derivatives. Preparation and crystal structures of calcium and cadmium complexes of methyl (E)-α-hydroxyiminobenzylphosphonate (1989) (9)
- A new, convenient, and efficient route to dimolybdenum(II) compounds from molybdenum oxide (MoO3) (1980) (9)
- Crystal and Molecular Structure of cis-(Pt(NH3)2(d(pGpG))), the Principal Adduct Formed by cis-Diamminedichloroplatinum(II) with DNA. (1989) (8)
- Evaluation of the N-phthaloyl moiety as protecting group in aminoacylphosphonic derivatives (1991) (8)
- Preparation, cytotoxicity and interactions with nucleophiles of three isomeric transplatinum complexes containing methylpiperidine ligands. (2005) (8)
- Mass spectrometric studies of the formation and reactivity of trans-[PtCl2(Am)(piperidinopiperidine)] x HCl complexes with ubiquitin. (2005) (8)
- Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand. (2013) (7)
- Zygote serine decreased uptake from the fertilization medium is associated with implantation and pregnancy (2014) (7)
- Probing the Interactions of Cytotoxic [Pt(1S,2S‐DACH)(5,6‐dimethyl‐1,10‐phenanthroline)] and Its PtIV Derivatives with Human Serum (2017) (7)
- Toxicity in tumor cells, DNA binding mode, and resistance to decomposition by sulfur nucleophiles of new dinuclear bifunctional trans-PtII complexes containing long alkane linkers (2012) (7)
- The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions. (2015) (6)
- Cyanide substitution in aryl halides by copper(I) complexes derived from formamide and from formaldehyde oxime (1987) (6)
- Rearrangement and Fragmentation Reactions of α-Hydroxyiminophoshinates. On the Nature of the Metaphosphonate Intermediate Involved in Phosphonylations by α-Hydroxyiminophosphinate (1990) (6)
- Preparation, Structure and Stability of cis-{Cr(phen)(2)[OP(O)(OC(6)H(5))(2)](H(2)O)}(2+) as a Model for Cr(III)-DNA Adducts. (1998) (6)
- Preparation and Structural Characterization of a Novel Hexanuclear Complex of Platinum(II) with 2-Aminoethanethiolate. (1986) (6)
- Tetrachloro-phosphonium salts of hexachloro antimonate and niobate and their solvates. Preparation and structure by vibrational spectroscopy and x-ray crystallography (1985) (6)
- Conformational studies of substituted five-membered cyclic carbonates and related compounds by MNDO, and the X-ray crystal structure of 4-chlorophenyloxymethyl-l,3-dioxolan-2-one (1989) (5)
- Mass spectrometry of biomolecules (2000) (4)
- The effect of cis-platin analogues derived from aminoalkylaminoanthraquinones on DNA cleavage: an electron microscopy study (1988) (4)
- Formaldehyde oxime as a precursor to cyanide in mixed-valence copper(I,II) complexes. Hydration of nitrite solvents (1986) (4)
- Tritungsten(IV) cluster compounds with hydroxo ligands. Preparation and structure of [W3O2(O2CCH3)6(H2O)(OH)2]·16H2O and [W3O2(O2CCH3)6(H2O)(OH)2]·KBr·15H2O (1985) (4)
- Formamide as a precursor to cyanide in mixed-valence copper(I,II) cyanide complexes (1986) (3)
- Pt(IV) Anticancer Prodrugs – A Tale of Mice and Men (2021) (3)
- Novel cytotoxic trans-diaminedichloro platinum(II) complexes with nonplanar heterocyclic ligands, preparation, cytotoxicity and DNA binding properties (2003) (3)
- Ligand effects on the binding of cis- and trans-[PtCl(2)Am(1)Am(2)] to proteins. (2003) (3)
- of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action † (2016) (3)
- Structure and Reactivity of 2-Hydroxyiminobenzyl-2-oxo-4,4,5,5-tetramethyl[1,3,2]dioxaphospholanes (1989) (3)
- Oxidation of cis-diamminediacetato Pt(II) with hydrogen peroxide can give rise to two isomeric Pt(IV) products. (2020) (2)
- Study of the DNA binding mechanism and in vitro activity against cancer cells of iron(III) and aluminium(III) kojic acid derivative complexes. (2022) (2)
- THE HYDROGEN OXIDE BRIDGING LIGAND (H3O2-). 2. EFFECT OF THE HYDROGEN ION CONCENTRATION (1984) (2)
- Platinum(II) triamine complexes: cis-[PtCl(NH3)2(C10H13N5O5)]NO3.2H2O and [PtCl(C2H8N2)(C4H6N2)]NO3. (1994) (1)
- Iron Chelators of the Pyridoxal 2-Pyridyl Hydrozone Class. Part III. Ionsation and Conformational Characteristics of the Ligands (1995) (1)
- Hydrogen oxide (H3O2) bridge formation in trinuclear metal cluster systems. The structure of [W3O2(O2CCH3)6(H2O)(H3O2)] NCS·H2O (1985) (1)
- Oxoplatin‐Based Pt(IV) Lipoate Complexes and Their Biological Activity (2022) (1)
- Synthesis and NMR Structural Studies of the Adduct of trans-Diamminedichloroplatinum(II) with the DNA Fragment d(GpCpG). (1987) (1)
- OXALATO COMPLEXES OF THE TRINUCLEAR AQUO ION OF MOLYBDENUM(IV), (MO3O4)4+ (1985) (1)
- Formaldehyde Oxime as a Precursor to Cyanide in Mixed-valence Copper(I,II) Complexes. Hydration of Nitrile Solvents. (1987) (0)
- α-Hydroxyiminophosphonic Acids. New Types of Phosphorylating Agents Through Monomeric Metaphosphate. (1988) (0)
- Conformational Studies of Substituted Five-Membered Cyclic Carbonates and Related Compounds by MNDO, and the X-Ray Crystal Structure of 4-Chlorophenyloxymethyl-1,3-dioxolan-2-one (1990) (0)
- Rearrangement and Fragmentation Reactions of α-Hydroxyiminophosphinates. On the Nature of the Metaphosphonate Intermediate Involved in Phosphonylations by α-Hydroxyiminophosphinate. (1990) (0)
- TRINUCLEAR MOLYBDENUM(IV) CLUSTER ION WITH A PROPYLIDYNE CAP (1982) (0)
- Possible Toxic Components in Smoked Fish Products (1981) (0)
- HYDROGEN OXIDE (H3O2) BRIDGE FORMATION IN TRINUCLEAR METAL CLUSTER SYSTEMS. THE STRUCTURE OF (W3O2(O2CCH3)6H2O)(H3O2))NCS.H2O (1985) (0)
- Inner-Shell Photodetachment of Nickel Negative Ions (2015) (0)
- Tritungsten(IV) Cluster Compounds with Hydroxo Ligands. Preparation and Structure of [W3O2(O2CCH3)6(H2O)(OH)2]·16 H2O and [W3O2( O2CCH3)6(H2O)(OH)2]·KBr·15 H2O. (1986) (0)
- Metal Complexes of α-Hydroxyiminophosphonic Acid Derivatives. Preparation and Crystal Structures of Calcium and Cadmium Complexes of Methyl (E)-α-Hydroxyiminobenzylphosphonate. (1990) (0)
- Tetrachloro-phosphonium Salts of Hexachloro Antimonate and Niobate and Their Solvates. (1986) (0)
- Analogues d'acides nucleiques peptidiques charges positivement a proprietes ameliorees (2001) (0)
- Reactions of Phosphorus Pentachloride with Tin Tetrachloride. Tetrachlorophosphonium Salts with Das SnCl6‐, Sn2Cl102‐ , und SnCl5‐ Anions: Preparation and Structure by Vibrational Spectra und X‐Ray Crystallography. (1985) (0)
- Investigating Electronic Properties and Bound-Bound Transitions in the Negative Ion of Lanthanum (2012) (0)
- Evaluation of the N‐Phthaloyl Moiety as Protecting Group in Aminoacylphosphonic Derivatives. (1991) (0)
- Stereoselectivity in Fragmentation and Rearrangement of α- Hydroxyiminophosphinates and -phosphonates. A Synthetic Approach to Acylphosphon- and -phosphor-amidates. Crystal Structures of Methyl (E)- α-Hydroxyiminobenzylphenylphosphinate and Methyl Benzoylphenylphosphonamidate. (1991) (0)
- Dibenzofuran annulated 1-azepines: Synthesis and cytotoxicity (2020) (0)
- Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands (2023) (0)
- ChemInform Abstract: Dicopper(I) Tropocoronands: Synthesis, X-Ray Crystal Structure, and Spectral Properties of Neutral Binuclear Copper(I) Complexes Bridged by Symmetrically Substituted Alkynes. (1986) (0)
- Cyanide Substitution in Aryl Halides by Copper(I) Complexes Derived from Formamide and from Formaldehyde Oxime. (1987) (0)
- Front Cover: Oxoplatin‐Based Pt(IV) Lipoate Complexes and Their Biological Activity (Chem. Biodiversity 10/2022) (2022) (0)
- Preparation,characterization and anticancer activity of novel platinum linked interactions (1989) (0)
- Novel Amino Acid Derivatives. Preparation and Properties of Aminoacylphosphonates and Amino Hydroxyimino Phosphonates. (1991) (0)
- Acylphosphonamidates and α‐Hydroxyiminophosphonamidates. Synthesis of N‐Acylphosphordiamidates by Beckmann Rearrangement. Crystal Structure of (E)‐α‐Hydroxyiminobenzyl‐1‐ pyrrolidinylphosphinate. (1997) (0)
- Platinum anticancer agents-Some facts, figures, question marks and speculations (2005) (0)
- Oral Anticancer Heterobimetallic PtIV-AuI Complexes Show High In Vivo Activity and Low Toxicity. (2023) (0)
- CCDC 606085: Experimental Crystal Structure Determination (2007) (0)
- Inner-Shell Photodetachment of the Carbon Anions Chain (2015) (0)
- Epigenetic and antitumor effects of platinum(IV)-octanoato conjugates (2017) (0)
- Structure and Reactivity of 2-Hydroxyiminobenzyl-2-oxo-4,4,5,5-tetramethyl(1,3,2)dioxaphospholanes. (1989) (0)
- Metal Complexes of α‐Hydroxyimino Phosphonic Acid Derivatives. Separation of the E and Z Isomers by Metal Chelation and the Preparation and Characterization of Copper Bis((E)‐(α‐(hydroxyimino)benzyl)phosphonate)‐Water. (1989) (0)
- Formamide as a Precursor to Cyanide in Mixed-valence Copper(I,II) Cyanide Complexes. (1986) (0)
- Novel oxaliplatin(IV) complexes conjugated with ligands bearing pendant 1,2-dithiolane/1,2-diselenolane/cyclopentyl motifs. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Dan Gibson?
Dan Gibson is affiliated with the following schools:
